Clinical Trials Directory

Trials / Completed

CompletedNCT03241862

Assess the Impact of Lip Rejuvenation on Projected First Impressions and Mood Perceptions

Assess the Impact of Lip Rejuvenation With Restylane® Silk on Projected First Impressions and Mood Perceptions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
DeNova Research · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

20 subjects with mild to severe oral commissures or none to severe perioral lines will be enrolled and injected with Restylane® Silk. Photographs will be taken prior to and 14 days after Optimal Cosmetic Results has been achieved, as judged by the investigator. Changes in the projected first impression will be assessed by a total of 200 blinded evaluators rating the photographs of subjects from the baseline and from 14 days post achieving the Optimal Cosmetic Results. Changes in subjects' mood will be self-assessed through Subjective Happiness Scale and Happiness Measures questionnaires. Aesthetic alterations will be assessed by the investigator via the Global Aesthetic Improvement Scale, Oral Commissure Severity Scale, and the Perioral Lines Severity Scale as well as by the self-assessment of subjects using the Global Aesthetic Improvement Scale.

Conditions

Interventions

TypeNameDescription
DEVICERestylane® SilkRestylane® Silk (Galderma Laboratories, L.P.) is a hyaluronic acid injectable filler, which is approved by the FDA for submucosal implantation for lip augmentation and dermal implantation for correction of perioral rhytids.

Timeline

Start date
2015-09-01
Primary completion
2017-06-01
Completion
2017-06-16
First posted
2017-08-08
Last updated
2020-11-04
Results posted
2020-11-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03241862. Inclusion in this directory is not an endorsement.